Skip to Content

M R21 (Repaglinide 0.5 mg)

Pill with imprint M R21 is White, Round and has been identified as Repaglinide 0.5 mg. It is supplied by Mylan Pharmaceuticals Inc..

Repaglinide is used in the treatment of diabetes, type 2 and belongs to the drug class meglitinides. Risk cannot be ruled out during pregnancy. Repaglinide 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M R21

Repaglinide 0.5 mg M R21
Repaglinide 0.5 mg M R21
Repaglinide 0.5 mg M R21 Front
Repaglinide 0.5 mg M R21 Back
Repaglinide 0.5 mg M R21

Repaglinide

Imprint
M R21
Strength
0.5 mg
Color
White
Shape
Round
Availability
Prescription only
Drug Class
Meglitinides
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00378-3121 Mylan Pharmaceuticals Inc.
51079-0062 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Related Images for "M R21"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.